|
1 |
Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma
Liang, Huan-Chang. - Würzburg : Universität Würzburg, 2024
|
|
|
2 |
Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 82, 2022, Nr. 10: 1055-1067
|
|
|
|
3 |
Surface states by grinding thin strips of electrochemically deposited nanocrystalline nickel-iron
Enthalten in Materials testing Bd. 64, 2022, Nr. 7: 903-931. 29 S.
|
|
|
|
4 |
A Service-Oriented Real-Time Communication Scheme for AUTOSAR Adaptive Using OPC UA and Time-Sensitive Networking
Arestova, Anna. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2021
|
|
|
|
5 |
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Bärtsch, Marc-Andrea. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2021
|
|
|
|
6 |
Mechanical behavior of annealed electrochemically deposited nanocrystalline nickel-iron alloys
Enthalten in Materials testing Bd. 62, 2020, Nr. 3: 225-241. 17 S.
|
|
|
|
7 |
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma
Bärtsch, Marc-Andrea. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2017
|
|
|
|
8 |
Entwicklung eines Systems zur Untersuchung des Richtungshörens in "Real Life Conditions"
Enthalten in GMS current posters in otorhinolaryngology, head and neck surgery Bd. 13, 26.04.2017
|
|
|
|
9 |
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Enthalten in Blood cancer journal Bd. 11, 7.1.2021, Nr. 1, date:1.2021: 1-10
|
|
|
|
10 |
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma
Enthalten in BMC cancer Bd. 16, 25.4.2016, Nr. 1, date:12.2016: 1-10
|
|
Administration
